Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11352607 Genomic engineering of pluripotent cells

Patent 11352607 was granted and assigned to Fate Therapeutics on June, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 16 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2023
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Bahram Valamehr0
Raedun Clarke0
Ramzey Abujarour0
Ryan Bjordahl0
Tom Tong Lee0
Weijie Lan0
Edits on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Edits on 5 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 5 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Fate Therapeutics
Fate Therapeutics
0
Current Assignee
Fate Therapeutics
Fate Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
113526070
Date of Patent
June 7, 2022
0
Patent Application Number
166564840
Date Filed
October 17, 2019
0
Patent Citations
‌
US Patent 11162075 Methods and compositions for inducing hematopoietic cell differentiation
0
‌
US Patent 11162076 Methods and compositions for inducing hematopoietic cell differentiation
0
‌
US Patent 10287606 Genomic engineering of pluripotent cells
0
‌
US Patent 10464989 Polypeptides, cells, and methods involving engineered CD16
0
‌
US Patent 10626372 Methods and compositions for inducing hematopoietic cell differentiation
0
‌
US Patent 10858628 Methods and compositions for inducing hematopoietic cell differentiation
0
‌
US Patent 10947505 Methods and compositions for inducing hematopoietic cell differentiation
0
‌
US Patent 11072781 Genomic engineering of pluripotent cells
0
Patent Primary Examiner
‌
Marcia S Noble
0
CPC Code
‌
C12N 15/85
0
‌
C12N 5/0696
0
‌
C12N 2506/11
0
Edits on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 9 Jun, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 9 Jun, 2022
Edits made to:
Infobox (+20 properties)
Article (+387 characters)
‌

 US Patent 11352607 Genomic engineering of pluripotent cells

Article

Provided are methods and compositions for obtaining genome-engineered iPSCs, and derivative cells with stable and functional genome editing at selected sites. Also provided are cell populations or clonal cell lines derived from genome-engineered iPSCs, which comprise targeted integration of one or more exogenous polynucleotides, and/or in/dels in one or more selected endogenous genes.

Infobox
Is a
Patent
Patent
Patent applicant
Fate Therapeutics
Fate Therapeutics
Current assignee
Fate Therapeutics
Fate Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11352607
Date of patent
June 7, 2022
Patent application number
16656484
Date Filed
October 17, 2019
Patent citations
‌
US Patent 11162075 Methods and compositions for inducing hematopoietic cell differentiation
‌
US Patent 11162076 Methods and compositions for inducing hematopoietic cell differentiation
‌
US Patent 10287606 Genomic engineering of pluripotent cells
‌
US Patent 10464989 Polypeptides, cells, and methods involving engineered CD16
‌
US Patent 10626372 Methods and compositions for inducing hematopoietic cell differentiation
‌
US Patent 10858628 Methods and compositions for inducing hematopoietic cell differentiation
‌
US Patent 10947505 Methods and compositions for inducing hematopoietic cell differentiation
‌
US Patent 11072781 Genomic engineering of pluripotent cells
Patent primary examiner
‌
Marcia S Noble
CPC Code
‌
C12N 15/85
‌
C12N 5/0696
‌
C12N 2506/11

Find more entities like US Patent 11352607 Genomic engineering of pluripotent cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.